Repurposing the serotonin agonist Tegaserod as an anticancer agent in melanoma: molecular mechanisms and clinical implications
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Repurposing the serotonin agonist Tegaserod as an anticancer agent in melanoma: molecular mechanisms and clinical implications ; volume:39 ; number:1 ; day:21 ; month:2 ; year:2020 ; pages:1-16 ; date:12.2020
Journal of experimental & clinical cancer research ; 39, Heft 1 (21.2.2020), 1-16, 12.2020
- Creator
-
Liu, Wei
Stachura, Paweł
Xu, Haifeng C.
Umesh Ganesh, Nikkitha
Cox, Fiona
Wang, Ruifeng
Lang, Karl S.
Gopalakrishnan, Jay
Häussinger, Dieter
Homey, Bernhard
Lang, Philipp A.
Pandyra, Aleksandra A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13046-020-1539-7
- URN
-
urn:nbn:de:101:1-2020051721334072795668
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Liu, Wei
- Stachura, Paweł
- Xu, Haifeng C.
- Umesh Ganesh, Nikkitha
- Cox, Fiona
- Wang, Ruifeng
- Lang, Karl S.
- Gopalakrishnan, Jay
- Häussinger, Dieter
- Homey, Bernhard
- Lang, Philipp A.
- Pandyra, Aleksandra A.
- SpringerLink (Online service)
Other Objects (12)
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents
Serotonin und Schlaf : die Befunde mit Agonisten
Drug repurposing against COVID-19: focus on anticancer agents
Therapie der opioidinduzierten Atemdepression durch Serotonin-Rezeptor-Agonisten
Repurposing metformin as a potential anticancer agent using in silico technique
Pharmacological challenge with a serotonin 1D agonist in alcohol dependence
Anticancer effect of terpenes: focus on malignant melanoma
Repurposing of anticancer drugs: in vitro and in vivo activities against Schistosoma mansoni
Anti-cancer effect of dung beetle glycosaminoglycans on melanoma
Anticancer effects of mifepristone on human uveal melanoma cells
Anti-cancer effects of lucidadiol against malignant melanoma cells
Drug repurposing
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents
Serotonin und Schlaf : die Befunde mit Agonisten
Drug repurposing against COVID-19: focus on anticancer agents
Therapie der opioidinduzierten Atemdepression durch Serotonin-Rezeptor-Agonisten
Repurposing metformin as a potential anticancer agent using in silico technique
Pharmacological challenge with a serotonin 1D agonist in alcohol dependence
Anticancer effect of terpenes: focus on malignant melanoma
Repurposing of anticancer drugs: in vitro and in vivo activities against Schistosoma mansoni
Anti-cancer effect of dung beetle glycosaminoglycans on melanoma
Anticancer effects of mifepristone on human uveal melanoma cells
Anti-cancer effects of lucidadiol against malignant melanoma cells
Drug repurposing
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents
Serotonin und Schlaf : die Befunde mit Agonisten
Drug repurposing against COVID-19: focus on anticancer agents
Therapie der opioidinduzierten Atemdepression durch Serotonin-Rezeptor-Agonisten
Repurposing metformin as a potential anticancer agent using in silico technique
Pharmacological challenge with a serotonin 1D agonist in alcohol dependence
Anticancer effect of terpenes: focus on malignant melanoma
Repurposing of anticancer drugs: in vitro and in vivo activities against Schistosoma mansoni
Anti-cancer effect of dung beetle glycosaminoglycans on melanoma
Anticancer effects of mifepristone on human uveal melanoma cells
Anti-cancer effects of lucidadiol against malignant melanoma cells